Sorry, you need to enable JavaScript to visit this website.

TOPOTECAN (topotecan injection) Overdosage

10 OVERDOSAGE

Overdoses (up to 10-fold of the recommended dose) have occurred in patients receiving intravenous topotecan. The primary complication of overdosage is myelosuppression. Elevated hepatic enzymes, mucositis, gastrointestinal toxicity and skin toxicity have occurred with overdosages. If an overdose is suspected, monitor the patient closely for myelosuppression and institute supportive-care measures as appropriate.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No